US 10398721
Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA
granted A61KA61K31/713A61K47/6455
Quick answer
US patent 10398721 (Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/713, A61K47/6455, A61P, A61P43/00